v3.26.1
Business Combinations - Summary of Preliminary Estimated Fair Values of Assets Acquired and Liabilities Assumed (Detail) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Nov. 12, 2025
Assets Acquired      
Goodwill $ 42,717 $ 43,363  
BioMedomics, Inc      
Assets Acquired      
Other current and non current assets     $ 10
Inventory     284
Operating right-of-use assets     120
In-process research and development technology intangible asset     1,900
Goodwill     1,775
Total assets acquired     4,089
Liabilities Assumed      
Accounts payable     34
Current liabilities     17
Deferred revenue     72
Operating lease liability     120
Total liabilities assumed     243
Net Assets Acquired     3,846
Estimated fair value of contingent consideration     (233)
Net Cash Paid     3,613
Cash acquired in excess of payments to acquire business     $ 25